ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
stotes
|
51 |
20K |
15 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
51
|
20K
|
15
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
stotes
|
51 |
20K |
8 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
51
|
20K
|
8
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
stotes
|
51 |
20K |
7 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
51
|
20K
|
7
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
stotes
|
51 |
20K |
8 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
51
|
20K
|
8
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Insights Confirm Diagnostic & Clinical Viability
|
|
stotes
|
51 |
20K |
26 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
51
|
20K
|
26
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
stotes
|
35 |
8.6K |
4 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
35
|
8.6K
|
4
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
stotes
|
35 |
8.6K |
5 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
35
|
8.6K
|
5
|
|
ASX - By Stock
|
EMV |
Re:
Ann: ASA Milestone Achieved for $0.6m Grant Payment
|
|
stotes
|
4 |
1.9K |
21 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4
|
1.9K
|
21
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.8K |
1.6M |
2 |
11/03/24 |
11/03/24 |
Charts
|
2.8K
|
1.6M
|
2
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
stotes
|
35 |
8.6K |
4 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
35
|
8.6K
|
4
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Board Changes
|
|
stotes
|
17 |
5.8K |
8 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
17
|
5.8K
|
8
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
stotes
|
35 |
8.6K |
4 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
35
|
8.6K
|
4
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Appendix 4D - Half Year Accounts - 31 December 2023
|
|
stotes
|
35 |
8.6K |
8 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
35
|
8.6K
|
8
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.8K |
1.6M |
5 |
04/03/24 |
04/03/24 |
Charts
|
2.8K
|
1.6M
|
5
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Broward Health signs 2 year agreement for rollout HeraCARE
|
|
stotes
|
36 |
9.0K |
7 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
36
|
9.0K
|
7
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.8K |
1.6M |
3 |
04/03/24 |
04/03/24 |
Charts
|
2.8K
|
1.6M
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
15 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
2.6K
|
1.2M
|
15
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Becoming a substantial holder
|
|
stotes
|
1 |
833 |
17 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
1
|
833
|
17
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.8K |
1.6M |
11 |
29/02/24 |
29/02/24 |
Charts
|
2.8K
|
1.6M
|
11
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
13 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
2.6K
|
1.2M
|
13
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Strategic A$15.28M Investment from Keysight Technologies
|
|
stotes
|
45 |
19K |
30 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
45
|
19K
|
30
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
2.6K
|
1.2M
|
1
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
16 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
2.6K
|
1.2M
|
16
|
|
ASX - By Stock
|
EMV |
Re:
Crossings, Special Crossings ETC
|
|
stotes
|
4 |
1.1K |
10 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
4
|
1.1K
|
10
|
|
ASX - By Stock
|
EMV |
Crossings, Special Crossings ETC
|
|
stotes
|
4 |
1.1K |
9 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
4
|
1.1K
|
9
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.8K |
1.6M |
7 |
21/02/24 |
21/02/24 |
Charts
|
2.8K
|
1.6M
|
7
|
|
Charts
|
HMD |
Re:
HMD Chart
|
|
stotes
|
677 |
182K |
5 |
26/01/24 |
26/01/24 |
Charts
|
677
|
182K
|
5
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.8K |
1.6M |
17 |
16/01/24 |
16/01/24 |
Charts
|
2.8K
|
1.6M
|
17
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Strategic collaboration and commercial agreement with GPEx
|
|
stotes
|
9 |
2.2K |
3 |
16/01/24 |
16/01/24 |
ASX - By Stock
|
9
|
2.2K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
8 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
2.6K
|
1.2M
|
8
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.8K |
1.6M |
17 |
08/01/24 |
08/01/24 |
Charts
|
2.8K
|
1.6M
|
17
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
23 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
2.6K
|
1.2M
|
23
|
|
ASX - By Stock
|
EMV |
Re:
EMV on ABC news - getting exciting now!
|
|
stotes
|
22 |
11K |
14 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
22
|
11K
|
14
|
|
ASX - By Stock
|
NIS |
Re:
NIS chart
|
|
stotes
|
651 |
155K |
8 |
30/12/23 |
30/12/23 |
ASX - By Stock
|
651
|
155K
|
8
|
|
ASX - By Stock
|
EMV |
Re:
Ann: EMVision Receives $2.58m R&D Rebate & ASA Milestone Achieved
|
|
stotes
|
5 |
2.9K |
21 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
5
|
2.9K
|
21
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
2 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
2.6K
|
1.2M
|
2
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
12 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
2.6K
|
1.2M
|
12
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
10 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
2.6K
|
1.2M
|
10
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
17 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
2.6K
|
1.2M
|
17
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Becoming a substantial holder
|
|
stotes
|
5 |
2.1K |
2 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
5
|
2.1K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
17 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
2.6K
|
1.2M
|
17
|
|
ASX - By Stock
|
BGT Biotech |
Re:
BioGene Media
|
|
stotes
|
102 |
35K |
4 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
102
|
35K
|
4
|
|
Charts
|
EMV |
Re:
Chart
|
|
stotes
|
2.8K |
1.6M |
18 |
28/11/23 |
28/11/23 |
Charts
|
2.8K
|
1.6M
|
18
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Stage 2 Trial Recruitment Tartget Reached & EMU Unveiled
|
|
stotes
|
7 |
3.7K |
18 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
7
|
3.7K
|
18
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
6 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
2.6K
|
1.2M
|
6
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
stotes
|
2.6K |
1.2M |
3 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
2.6K
|
1.2M
|
3
|
|
ASX - By Stock
|
BGT |
Re:
Ann: BGT 2023AGM - Chairman's Address
|
|
stotes
|
11 |
2.7K |
5 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
11
|
2.7K
|
5
|
|
ASX - By Stock
|
BGT |
Re:
Ann: BGT 2023AGM - Chairman's Address
|
|
stotes
|
11 |
2.7K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
11
|
2.7K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
AGM 2023
|
|
stotes
|
44 |
12K |
22 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
44
|
12K
|
22
|
|
ASX - By Stock
|
RC1 |
Re:
Ann: Annual Report to shareholders
|
|
stotes
|
7 |
3.6K |
4 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
7
|
3.6K
|
4
|
|